Navigation Links
Shire Proposes to Expand Specialist Gastrointestinal Portfolio
Date:8/3/2010

zation and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

DEUTSCHE BANK AG

Deutsche Bank AG is authorized under German Banking Law (competent authority: BaFin - Federal Financial Supervisory Authority) and authorized and subject to limited regulation by the FSA. Details about the extent of Deutsche Bank AG's authorization and regulation by the FSA are available on request.

    (i)   WGO Practice Guidelines - http://www.medscape.com/
    (ii)  Johanson Kralstein. Chronic constipation: a survey of the patient
          perspective. Aliment Pharmacol Ther 2007; 25:599-608
    (iii) Mertz H, Naliboff B, Mayer E. Physiology of refractory chronic
          constipation. Am J Gastroenterol 1999; 94:609-15.



    For further information please contact:

    Investor Relations:
    Eric Rojas, erojas@shire.com, +1-781-482-0999

    Media:
    Jessica Mann, 
SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
2. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
3. Shire plc Appoints Two New Board Directors
4. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
5. Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection)
6. INTUNIV(TM) - Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc.
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals
9. Shire Supports Rare Disease Day 2010
10. Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease
11. Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that the ... Horiba Scientific, have organized a session on nanotechnology for ... , Asia’s largest analytical and scientific instruments show, will ... , The four speakers in this U.S. symposium, ... to Single Cells” will present their use of nanotechnology ...
(Date:8/29/2014)... August 29, 2014 A major challenge ... biotech start-up dense realm of Boston-Cambridge, is gaining visibility ... investors. James Sherley, the Director of Boston’s Adult Stem ... local and national visibility of his company an important ... , In addition to a social media marketing ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and ... 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for ... owners and USDA-GIPSA inspection agencies that have a need to ... place in a matter of minutes with nothing but our ... feed and grain before accepting it, but they no longer ...
(Date:8/28/2014)... executives from clinical trial marketing firm BBK Worldwide will lead ... Clinical Trials 2014 , to be held at the Hyatt ... Patient recruitment experts Bonnie A. Brescia , Matthew ... on the benefits of employing an effective patient engagement strategy, ... mobile apps – can be used to drive study participation ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2
... 3, 2011 Genomic Health, Inc. (Nasdaq: GHDX ) ... March 31, 2011. Total revenue increased to $49.8 million ... the first quarter of 2010.  Product revenue was $49.5 million in ... with $40.3 million in the first quarter of 2010. ...
... N.C., May 3, 2011 Talecris Biotherapeutics Holdings Corp. (NASDAQ: ... today in Chapel Hill, N.C., where four proposals were submitted ... directors to the company,s Board of Directors to hold office ... in 2014, and until their successors are elected and qualified. ...
... NEW YORK, May 3, 2011 Reportlinker.com announces that ... catalogue: Medical Enzymes: Technologies and Global ... The market for enzymes in medicine is growing. ... $6 billion in 2010. The market is growing at ...
Cached Biology Technology:Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 8Talecris Biotherapeutics Announces Results of Annual Stockholders' Meeting 2Reportlinker Adds Medical Enzymes: Technologies and Global Markets 2Reportlinker Adds Medical Enzymes: Technologies and Global Markets 3Reportlinker Adds Medical Enzymes: Technologies and Global Markets 4Reportlinker Adds Medical Enzymes: Technologies and Global Markets 5Reportlinker Adds Medical Enzymes: Technologies and Global Markets 6Reportlinker Adds Medical Enzymes: Technologies and Global Markets 7Reportlinker Adds Medical Enzymes: Technologies and Global Markets 8Reportlinker Adds Medical Enzymes: Technologies and Global Markets 9Reportlinker Adds Medical Enzymes: Technologies and Global Markets 10Reportlinker Adds Medical Enzymes: Technologies and Global Markets 11Reportlinker Adds Medical Enzymes: Technologies and Global Markets 12Reportlinker Adds Medical Enzymes: Technologies and Global Markets 13
(Date:8/28/2014)... the developmental on-off switch for Streptomyces , a ... of the world,s naturally derived antibiotic medicines. , ... is possible to manipulate this switch to make nature,s ... August 28 in Cell , found that a ... a larger protein called BldD ultimately controls whether a ...
(Date:8/28/2014)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for the American College of Sports Medicine,s ... 17-20, 2014 in Miami, Florida. These awards ... post doctorates and scientists from underrepresented groups into ... to encourage the participation of young scientists at ...
(Date:8/28/2014)... August 28, 2014 Dyslexia, the most commonly ... a neurological reading disability that occurs when the ... don,t function normally. , The use of non-invasive ... activity is disrupted in dyslexia. However, most prior ... of brain regions, leaving a gap in our ...
Breaking Biology News(10 mins):Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3Dyslexic readers have disrupted network connections in the brain 2
... and animal studies released today uncover the extensive brain ... how the brain processes and produces language, accents, and ... people with speech and language problems, such as stuttering, ... at Neuroscience 2010, the annual meeting of the Society ...
... wave patterns formed from complex biochemical reactions within the ... says Zhengdong Cheng, associate professor in the Artie McFerrin ... has developed a model that simulates how these wave ... the October issue of the journal "Physical Review ...
... a unique program in East Harlem that helps middle ... better understanding of medical conditions, such as diabetes and ... medical careers among the students who attended the program. ... Association (APHA) Annual Meeting this month in Denver. ...
Cached Biology News:Communication engages complex brain circuitry and processes 2Research links damaged organs to change in biochemical wave patterns 2Program for young students increases interest in college attendance and medical careers 2
Rabbit polyclonal to UBC12 (rating: ****) ( Abpromise for all tested applications). Antigen: Synthetic peptide: RGGYIGSTYFER, corresponding to amino acids 169-180 of UBC12 Entrez Gene ID: 90...
GBL Antibody...
...
... Quality 96 Well BAC Prep; ... preparation from 1.5ml 2xYT cultures; ... automated fluorescent sequencing for small ... ProPrep strategy which minimizes shearing ...
Biology Products: